Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Miriam Sant’ Angelo et al.|Nature Medicine|2020Cited by 1k
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Nir Hacohen, Yunxin J. Jiao et al.|Nature Communications|2017Cited by 999
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genesSachet A. Shukla, Gad Getz|Nature Biotechnology|2015Cited by 692
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, Kelly Street et al.|Cancer Cell|2021Cited by 515
Clinical Validation of <i>PBRM1</i> Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell CarcinomaDavid A. Braun, Toni K. Choueiri, Yuko Ishii et al.|JAMA Oncology|2019Cited by 242